Methods: A systematic search of apps that were aimed at patients diagnosed with HMs, accessed from a Spain IP address, and were available on the iOS (App Store) and Android (Google Play) platforms was conducted in November 2021. Objective: The goal of this review was to identify and assess the quality of smartphone apps aimed at patients diagnosed with HMs. The chronification of HMs and the increasing use of smartphones may lead patients to seek their current unmet needs through mobile health apps. See correction statement in: Abstractīackground: Hematological malignancies (HMs) are a heterogeneous group of cancers representing a significant cause of morbidity and mortality. Related ArticleThis is a corrected version.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |